HEPS HEPS
Company Profile ↓Company Overview
HEPS (HEPS) is a publicly traded company listed on with a market capitalization of $1.03B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 30.3% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $84.65B (+13.4% YoY); net profit $-5.70B.
- Trailing 12 Months Year-on-year growth — revenue +13.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 30.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 30.34% |
| 1 Year: | 13.37% |
Stock Price Performance
| 1 Year: | +1.42% |
| 6 Months: | +6.34% |
| 3 Months: | +2.15% |
| 1 Month: | -3.06% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)47.20 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 30.3% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 18.83B | 16.74B | 19.92B | 30.34B | 23.14B |
| Cost of Revenue | 11.86B | 10.41B | 12.51B | 19.95B | 14.64B |
| Gross Profit | 6.97B | 6.34B | 7.41B | 10.38B | 8.50B |
| Operating Expenses | 7.48B | 6.30B | 8.00B | 10.11B | 8.94B |
| Operating Income | -513.93M | 34.05M | -590.55M | 277.41M | -439.57M |
| EBITDA | 2.72B | 2.34B | 2.38B | -5.52B | 2.92B |
| Interest Expense | 2.33B | 2.36B | 2.84B | -3.19B | 3.02B |
| Pretax Income | -464.69M | -723.82M | -1.32B | -3.23B | -961.22M |
| Tax Provision | 0 | 0 | 0 | -43.15M | 30.75M |
| Net Income | -464.69M | -723.82M | -1.32B | -3.19B | -991.97M |
| Diluted EPS | -1.40 | -2.30 | -4.10 | -10.00 | -2.70 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 38.23B | 67.20B | 74.67B | 84.65B |
| Cost of Revenue | - | 29.92B | 46.85B | 46.67B | 53.98B |
| Gross Profit | - | 8.31B | 20.35B | 28.00B | 30.67B |
| Operating Expenses | - | 14.84B | 21.57B | 27.43B | 31.57B |
| Operating Income | - | -6.53B | -1.21B | 566.71M | -901.62M |
| EBITDA | - | -4.89B | 4.97B | 4.33B | 1.64B |
| Interest Expense | - | 809.26M | 2.60B | 3.75B | 4.21B |
| Pretax Income | - | -6.92B | 142.74M | -2.10B | -5.74B |
| Tax Provision | - | 0 | 0 | 0 | -43.15M |
| Net Income | - | -6.92B | 142.74M | -2.10B | -5.70B |
| Diluted EPS | - | -4.06 | 0.23 | -4.90 | -18.00 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 16.59B | 25.38B | 34.22B | 36.95B |
| Current Assets | - | 13.80B | 21.11B | 27.30B | 29.67B |
| Cash & Equivalents | - | 8.68B | 7.94B | 8.84B | 11.31B |
| Inventory | - | 2.95B | 5.72B | 7.86B | 8.73B |
| Receivables | - | 955.88M | 3.43B | 6.60B | 6.24B |
| Total Liabilities | - | 13.22B | 20.61B | 29.87B | 34.93B |
| Current Liabilities | - | 12.76B | 19.70B | 28.25B | 33.39B |
| Long Term Debt | - | 18.00M | 4.05M | - | - |
| Total Debt | - | 471.81M | 668.00M | 3.50B | 2.43B |
| Total Equity | - | 3.37B | 4.77B | 4.35B | 2.01B |
| Shares Outstanding | - | 326.00M | 326.00M | 326.00M | 361.84M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 1.02B | 9.49B | 7.46B | 11.28B |
| Investing Cash Flow | - | 2.61B | -3.17B | 1.17B | 2.57B |
| Financing Cash Flow | - | -3.51B | -6.29B | -7.68B | -9.24B |
| Capital Expenditure | - | -2.01B | -2.18B | -2.63B | -2.41B |
| Free Cash Flow | - | -990.82M | 7.30B | 4.83B | 8.87B |
| Net Change in Cash | - | 119.94M | 20.43M | 950.87M | 4.61B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 21.7% | 30.3% | 37.5% | 36.2% |
| Operating Margin % | - | -17.1% | -1.8% | 0.8% | -1.1% |
| Net Margin % | - | -18.1% | 0.2% | -2.8% | -6.7% |
| ROE % | - | -205.5% | 3.0% | -48.3% | -283.3% |
| ROCE % | - | -170.8% | -21.4% | 9.5% | -25.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HEPS
D-MARKET Electronic Services & Trading (NASDAQ:HEPS) Stock Price Up 0.7% - Time to Buy? - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQdmQxQ1BXUlQzdmpaTVZiYVQ4eml5R2pXWDUwQXdleXBseXRjaGVzWVpHUlZXak9Tdmt3Rjlyd3hQbXNYOERPeGpVbGFyaVdQdUZFTTlWSHotMEt6ZjZqcXFBT01CNTlfODJQR0hQQ2gtbW9qX2dNZzNYOWVwczYyZzIxMGlYUjlQZHhiNE…
Hepsiburada's Q2 results are due after U.S. markets close Aug. 6 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNNF9qcS1PcjNydVg3bVFjdW1KMS1OWDdRUXMwa3VUVUtMUlZyYzBXQkdTWlEtdFFORndIMzdETGgxWTBnRlhzNkY0aUNtQjBiaVBwY0ZMTllxWEJMaWVZRTJXUVBLVDFtczBVdURhcF9sY0llQjN4ZVZVZWYydWhuejY4bnFLQjdyZjBOUG…
D-Market Elektronik Hizmetler Ve Ticaret (NasdaqGS:HEPS) Seeks Share Capital Increase, Is It A Bargain? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxQbW03X3gwZTM0NzRpV3NPWGozdmktVzh4MUxOTFVsQng0ZDdJNEQ5MmdqTFItMXR4S3oyaUtyN3JIR255aTk0WlNlcHpoSGF6UkpxVGVrYjZtYlVkWHFuOFpSN3dobjRHd0ZJejZYV1JYd19NWnBBRGVhTUN3VklBbEdqVHpBQzlLVjZYcT…
D-Market Electronic Services & Trading Revenue Breakdown – NASDAQ:HEPS - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1xOFNRdnFmNGVLeWxEVnBSM1h2V0NZYnNiQjdyQzlmYXQ1ckdBdWtIdFJQOENnU2hoeFdBekYxTWpRNnpjQ3JzR3p4M3NRb3pHWUMtRDg3TUk4VWdvT0ZHRkJxcFc3eFRId2VJTUx6VWNzZmkzZGNF?oc=5" target="_blank">D-Marke…
Hepsiburada Announces Extraordinary General Assembly Meeting to Approve Share Capital Increase - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQU2czczdsbHMtcC1qOVpvdVZvRmRHXzBiVW1Vd180ZEdDM3RyRXFMR0N3eUR1RkpKSURxanNPN0ZfN1JQelA5OU1iSkgxN0U4REoyYVVwQ0Y0bms5T2dlTFhUdC1hakdiSEh4bVpWdjlmbzNobWtVS0ZTVnBQd1ZGX0syRTNZU0FXblo4b1…
Kaspi.kz boosts D-MARKET (NASDAQ: HEPS) ownership stake to 86.74% - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOZng4VVpmVHh3UFJ6WW1CZURSamdlVU94Yk1IS2tQblp5bGNvVWRkX3VYUU16dmdfTFR0TDI3M0taRUNOY2ZGUWtPV0tmTTN6OVpGSjluLWZjM256SzMwZ09pZk9aOVNyam5lSk1lNFdoaGM0ZFZGdHhaRUdUaVl3S3FHQkRYakI0WXlvN2…
HEPS — Frequently Asked Questions
What is the current share price of HEPS?
As of 2026-08-05 17:25 PDT, HEPS trades at $2.85 on NASDAQ/NYSE. Its 52-week range is $2.18 to $3.29.
What is the market capitalisation of HEPS?
HEPS has a market capitalisation of $1.03B on NASDAQ/NYSE.
What is the P/E ratio of HEPS?
HEPS trades at a trailing price-to-earnings (P/E) ratio of -0.16. Its price-to-book (P/B) ratio is 0.51.
Is HEPS a good stock to buy?
This page provides a data-driven analysis of HEPS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.